Dermacon (0745.366.707): financials and annual accounts

CHECKED

Create an account

Companies

Search companies
Addresses
Company groups
Nearby
Service voucher comparison

People and firms

Directors
Bankruptcy trustees
Notaries

Events

Events: Overview
All events

Company changes

Incorporations
Director changes
Name changes
Registered office moves
Mergers and takeovers

Financial publications

Annual accounts filed
Capital changes
Auditor changes

Legal status & closure

Bankruptcies
Judicial reorganisations
Dissolutions and liquidations
Ex-officio strike-offs
Interim measures

Tools

Tools: Overview

Investigate

Analysis workbench
Compare companies
Sector benchmark
Employer check
Network investigator
Company wealth map
Lookalike companies
Company as of a date
Permit applications

Assess companies

Credit check
Supplier due diligence
AML client file
Creditor guide
Contractor check
Self-check
Public procurement exclusion grounds
Service voucher comparison

Market and sector

Sector figures
Municipality map
Subsidies
Market analysis
Trends
Rankings
Survival tables
Public contracts

Invoices and lists

Invoice check
Peppol check
Process a list

Starting out

Name check
Local market research
Starter mirror
Financial plan

NL FR EN

Nederlands Français English

My Checked

Sign in
Create an account

Home / Search companies / Engineering and related technical consultancy, excluding land surveyors / Dermacon / Financials

Dermacon

Oostrozebeke ·KBO/BCE: BE 0745.366.707

Loading dossier…

Checked · Insight, alerts and connections for every Belgian company, from official sources.

Based on official Belgian registers and filed annual accounts.

NL FR EN

Discover

All tools Sector figures Rankings Municipality map All events Company groups Trends Survival tables

Checked

About Checked Contact Pricing

Help and guides

Frequently asked questions Knowledge base

Integrations

API AI assistants Excel and Google Sheets Company badge

Legal

We would like to set cookies. That happens only with your consent. What we measure

Help us improve Checked

If something looks wrong or is missing, please tell us.

Your message Email (optional, only to reply)

Line	2026	2025	2024	2023	2022	2021
Balance sheet: assets
`20/58`	247,262	200,726	163,862	145,588	109,651	82,338
`21/28`	8,241	16,050	17,024	24,706	29,424	35,644
`22/27`	8,241	16,050	17,024	24,706	29,424	35,644
`23`	6,295	6,969	534	806	1,213	312
`24`	1,946	9,081	16,490	23,900	28,211	35,332
`29/58`	239,021	184,676	146,838	120,882	80,227	46,694
`40/41`	18,960	14,338	27,246	19,020	13,022	21,259
`40`	18,634	11,038	22,695	19,020	13,022	21,259
`41`	326	3,300	4,551	-	-	-
`50/53`	100,000	80,000	-	-	-	-
`54/58`	116,631	86,153	116,886	99,254	64,670	22,768
`490/1`	3,430	4,185	2,706	2,608	2,535	2,667
Balance sheet: equity and liabilities
`10/49`	247,262	200,726	163,862	145,588	109,651	82,338
`10/15`	171,765	171,765	133,067	97,480	60,402	31,981
`10/11`	4,000	4,000	4,000	4,000	4,000	4,000
`100`	-	-	-	-	-	4,000
`13`	167,765	167,765	129,067	93,480	56,402	27,981
`133`	167,765	167,765	129,067	93,480	56,402	27,981
`17/49`	75,497	28,961	30,795	48,108	49,249	50,357
`17`	-	-	-	6,959	14,494	21,969
`170/4`	-	-	-	6,959	14,494	21,969
`42/48`	75,497	28,961	30,794	41,146	34,751	28,382
`42`	-	-	6,959	7,534	7,475	7,416
`44`	2,198	-	927	2,168	407	230
`440/4`	2,198	-	927	2,168	407	230
`45`	8,699	13,123	13,656	25,373	21,900	15,275
`450/3`	8,699	13,123	13,656	25,373	21,900	15,275
`47/48`	64,600	15,838	9,252	6,071	4,969	5,461
`492/3`	-	-	1	3	4	6
Income statement
`9900`	80,204	80,578	72,494	73,480	62,519	53,462
`62`	11,806	13,151	12,341	12,087	12,256	12,019
`630`	8,370	8,493	7,682	7,598	7,509	406
`640/8`	1,223	1,350	779	501	685	95
`9901`	58,805	57,584	51,692	53,294	42,069	40,942
`75/76B`	1,953	897	-	-	-	-
`75`	1,953	897	-	-	-	-
`65/66B`	1,096	814	497	374	393	193
`65`	1,096	814	-	-	-	-
`66B`	-	-	497	374	393	193
`9903`	59,662	57,667	51,195	52,920	41,676	40,749
`67/77`	12,227	15,570	14,008	14,242	11,655	11,168
`9904`	47,435	42,097	37,187	38,678	30,021	29,581
`9905`	47,435	42,097	37,187	38,678	30,021	29,581
Appropriation of the result
`9906`	47,435	42,097	37,187	38,678	30,021	29,581
`691/2`	-	38,697	35,587	37,078	28,421	27,981
`6921`	-	38,697	35,587	37,078	28,421	27,981
`694/7`	47,435	3,400	1,600	1,600	1,600	1,600
`694`	47,435	-	1,600	1,600	1,600	1,600
`695`	-	3,400	-	-	-	-
Document	PDF	PDF	PDF	PDF	PDF	PDF

Financial year	Type	Filed	Reference	Document
31-03-2026	micro format	19-04-2026	2026-00082180	PDF
31-03-2025	micro format	04-09-2025	2025-00479458	PDF
31-03-2024	micro format	02-09-2024	2024-00447246	PDF
31-03-2023	micro format	18-04-2024	2024-00067194	PDF
31-03-2022	micro format	14-09-2022	2022-20428578	PDF
31-03-2021	micro format	21-09-2021	2021-67800148	PDF

2026	2025	2024	2023	2022	2021
67,175	66,077	59,374	60,892	49,578	41,348
55,805	50,590	44,869	46,276	37,530	29,987
561	7,518	0	2,880	1,289	36,050
30,478	-30,733	17,632	34,584	41,902	-
163,524	155,715	116,044	79,736	45,476	18,312
69.5%	85.6%	81.2%	67.0%	55.1%	38.8%
3.17	6.38	4.77	2.94	2.31	1.65
0.44	0.17	0.23	0.49	0.82	1.57
27.6%	24.5%	27.9%	39.7%	49.7%	92.5%
19.2%	21.0%	22.7%	26.6%	27.4%	35.9%
61.29	81.18	over 100	over 100	over 100	-

Item	31-03-2026	31-03-2025	31-03-2024	31-03-2023	31-03-2022
Tangible fixed assets	€561	€7,518	-	€2,880	€1,289
	€8,370	€8,493	€7,682	€7,598	€7,509

Dermacon

Annual accounts 2026

Balance sheet

in euro

in euro

Position in the sector

69.5%

3.17

19.2%

Filed annual accounts

Filings

Key figures and ratios

Investments

Insights on Dermacon

Next steps

Annual accounts 2026

Balance sheet

Change in equityin euro

Change in cashin euro

Position in the sector

Solvency69.5%

Current ratio3.17

Return on assets19.2%

Filed annual accounts

Filings

Key figures and ratios

Investments

Insights on Dermacon

Next steps

in euro

in euro

69.5%

3.17

19.2%